Table 2.
Anthropometric data, results of spirometry and spiroergometry of AWD patients and age-, sex- and BMI-matched controls. All data are displayed as mean ± standard deviation unless otherwise specified.
| AWD patients [n = 18] | Controls [n = 18] | p value | |
|---|---|---|---|
| Age | 12.6 ± 3.5 | 12.3 ± 3.3 | 0.798a |
| Anthropometry | |||
| Height [m] | 1.59 (0.28)a | 1.60 (0.24)a | 0.983** |
| Body Weight [kg] | 48.1 ± 16.7 | 49.7 ± 16.3 | 0.785* |
| BMI | 19.4 ± 4.4 | 19.7 ± 4.0 | 0.787* |
| Body Fat [%] | 13.8 (18.1)a | 10.8 (20.0)a | 0.888** |
| Muscle Mass [kg/Height²]b | 6.3 ± 1.3 | 6.2 ± 1.5 | 0.943* |
| Physical Activity Levelc | 2 (1)a | 2 (0)a | 0.521** |
| Spirometry | |||
| VCmax [L] | 2.9 ± 1.0 | 3.1 ± 1.1 | 0.558* |
| Tiffeneau Index [%] | 86.4 ± 7.6 | 86.5 ± 7.6 | 0.965* |
| Spiroergometry | n = 13d | n = 13d | |
| Relative Performance [%] | 97.9 ± 24.3 | 98.0 ± 20.3 | 0.986* |
| RER | 1.16 ± 0.08 | 1.14 ± 0.11 | 0.600* |
| Peak VO2 [ml/kg/min] | 40.3 (11.0)a | 39.7 (17.0)a | 0.555* |
| O2/HR [ml] | 11.0 (4.0)a | 11.2 (4.0)a | 0.751** |
| EQO2 | 21.7 ± 3.1 | 19.7 ± 2.4 | 0.071* |
| BR FEV% | 10.5 ± 10.8 | 14.2 ± 17.7 | 0.510* |
| QoL | |||
| GIQLI | 137.2 ± 6.8 | 141.4 ± 4.9 | 0.038* |
| Bristol Stool scale | 4 (1)a | 3 (1)a | 0.111** |
Statistically significant p-values are in bold.
AWD abdominal wall defect, m meter, kg kilogram, VCmax maximum vital capacity, RER respiratory exchange ratio, peak VO2 peak oxygen uptake, O2/HR oxygen pulse, EQO2 respiratory equivalent for oxygen, BR breathing reserve, FEV% Forced Expiratory Volume, QoL quality of life, GIQLI gastrointestinal quality of life index.
*Unpaired t test, ** Mann–Whitney-U test.
aMedian (IQR).
bn = 14, it was not possible to detect muscle mass in 4 cases.
cPhysical Activity Level (once per month=0, once per week=1 several times a week=2, daily=3).
dFive patients were not able to perform spiroergometry because they were too short for ergometry.